Target intelligence / Profile preview

DNA-directed RNA polymerase II subunit C (POLR2C)

Target
POLR2C
Molecular classification
Enzyme, Polymerase complex subunit, Core component of RNA polymerase II
01

Overview

DNA-directed RNA polymerase II subunit C (POLR2C) is the third-largest subunit of RNA polymerase II, a multi-protein enzyme complex essential for the transcription of protein-coding genes and many noncoding RNAs in eukaryotes. POLR2C forms a heterodimer with POLR2J, establishing a core subassembly crucial for RNA polymerase II stability and assembly. POLR2C contributes to the structure and function of the enzyme, supporting dimerization, promoter clearing, and elongation stages of transcription. Disruption in the RNA polymerase II pathway, including the POLR2C subunit, is implicated in cancer, neurodegeneration, and some genetic diseases, but direct targeting of POLR2C for therapy is not established.

Other names
RNA polymerase II subunit RPB3RNA polymerase II subunit 3RNA polymerase II subunit B3RPB3RPB33RPB31hRPB33hsRPB3DNA-directed RNA polymerase II 33 kDa polypeptideA-152E5.7polymerase (RNA) II (DNA directed) polypeptide C, 33kDapolymerase (RNA) II subunit C
02

Mechanism of action

Inhibition of polymerase II through toxin binding (e.g., α-amanitin disrupts mRNA synthesis by poisoning the entire enzyme complex) Indirect modulation via transcriptional regulation (not specific to POLR2C, but to complex-wide cofactors and inhibitors)

03

Biological functions

Messenger RNA (mRNA) synthesisNoncoding RNA synthesis (snRNA, microRNA)Transcription regulationProtein dimerizationAssembly and stability of RNA polymerase II complex
04

Disease associations

Cancer (disruption of transcription elongation, general RNA polymerase II dysfunction is implicated in cancer)Neurodegenerative disease (general dysfunction of RNA polymerase II complex)HIV infection (HIV transcription regulation interacts with RNA polymerase II pathway)Otitis media (genetic association)Nemaline myopathy 5A (genetic association)
05

Safety considerations

General toxicity with global polymerase II inhibition (cell death, toxicity in non-target tissues)Essential role in transcription—broad inhibition causes profound cytotoxicity, precluding targeting as a safe therapy
06

Interacting drugs

α-amanitin (a toxin, not therapeutic, but key for research)

1 more in the full profile.

07

Biomarkers

None specific for POLR2C in clinical practice; markers typically apply to RNA polymerase II activity as a whole

Beyond the preview

Go deeper on DNA-directed RNA polymerase II subunit C (POLR2C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA-directed RNA polymerase II subunit C (POLR2C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call